Doximity, Inc.
Case Overview
59 Days Left to Seek Lead Plaintiff
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 11/16/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: Doximity, Inc. |
| Court: | Court: Northern District of California |
| Case Number: | Case Number: 3:26cv10529 |
| Class Period: | Class Period: 08/08/2024 - 05/13/2026 |
| Ticker: | Ticker: DOCS |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
The lawsuit alleges that Defendants made false and/or misleading statements and failed to disclose: (i) the true impact that its Newsfeed had on the Company’s revenue growth; (ii) that the Company was losing market share to its competitors with more favorable pricing and engagement models; and (iii) Doximity relied heavily on both banner ads and email newsletters as advertising methods.
On November 6, 2025, Doximity expressed a degree of caution regarding the outlook for ad spending and implied a slowdown in sales growth during the second half of the 2026 fiscal year, which ended on March 31, 2026. On this news, the price of Doximity shares fell $8.29, or approximately 13%, from $62.58 per share on November 6, 2025 to close at $54.29 on November 7, 2025.
Then, on February 5, 2026, Doximity lowered its revenue guidance for fiscal year 2026 and announced that its sales growth had decelerated while its net income had contracted, which would negatively impact its 2026 fiscal fourth quarter. On this news, the price of Doximity shares fell $5.59, or approximately 17%, from $33.32 per share on February 5, 2026 to close at $27.73 on February 6, 2026.
On November 6, 2025, Doximity expressed a degree of caution regarding the outlook for ad spending and implied a slowdown in sales growth during the second half of the 2026 fiscal year, which ended on March 31, 2026. On this news, the price of Doximity shares fell $8.29, or approximately 13%, from $62.58 per share on November 6, 2025 to close at $54.29 on November 7, 2025.
Then, on February 5, 2026, Doximity lowered its revenue guidance for fiscal year 2026 and announced that its sales growth had decelerated while its net income had contracted, which would negatively impact its 2026 fiscal fourth quarter. On this news, the price of Doximity shares fell $5.59, or approximately 17%, from $33.32 per share on February 5, 2026 to close at $27.73 on February 6, 2026.